Olli Ritvos

Person

Senaste publikationer

  1. Soluble activin type IIB receptor improves fracture healing in a closed tibial fracture mouse model

    Puolakkainen, T., Rummukainen, P., Lehto, J., Ritvos, O., Hiltunen, A., Saamanen, A-M. & Kiviranta, R. 13 jul 2017 I : PLoS One. 12, 7, 16 s., 0180593

    Forskningsoutput: Vetenskaplig - Peer reviewArtikel

  2. Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy

    Puolakkainen, T., Ma, H., Kainulainen, H., Pasternack, A., Rantalainen, T., Ritvos, O., Heikinheimo, K., Hulmi, J. & Kiviranta, R. 19 jan 2017 I : BMC Musculoskeletal Disorders. 18, 11 s., 20

    Forskningsoutput: Vetenskaplig - Peer reviewArtikel

  3. Activin inhibition limits early innate immune response in rat kidney allografts-a pilot study

    Palin, N. K., Savikko, J., Pasternack, A., Rintala, J. M., Kalra, B., Mistry, S., Kumar, A., Roth, M-P., Helin, H. & Ritvos, O. jan 2017 I : Transplant International. 30, 1, s. 96-107 12 s.

    Forskningsoutput: Vetenskaplig - Peer reviewArtikel

Visa alla (98) »

ID: 15568